Stock-Based Compensation - Schedule of Stock-Based Compensation Expense (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Allocated Share-based Compensation Expense	$ 3,921	$ 2,310
Cost of revenue [Member]
Allocated Share-based Compensation Expense	49	25
Research, development and clinical trials expenses [Member]
Allocated Share-based Compensation Expense	518	321
Selling, general and administrative expenses [Member]
Allocated Share-based Compensation Expense	$ 3,354	$ 1,964